Which Neonatal Disorders Benefit from Synthesis Inhibition?
Several neonatal disorders can benefit from synthesis inhibition, including:
- Phenylketonuria (PKU): By inhibiting the synthesis of phenylalanine, the risk of neurotoxicity is reduced. - Congenital Adrenal Hyperplasia (CAH): Inhibiting the synthesis of specific steroids can help manage electrolyte imbalances and prevent adrenal crises. - Hyperinsulinism: Inhibiting insulin synthesis can help control hypoglycemia and prevent subsequent complications. - Urea Cycle Disorders: Inhibiting the synthesis of ammonia can prevent hyperammonemia and its toxic effects on the brain.
